Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 11 Breast Neoplasms 11 Neoplasm Metastasis 10 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasms 7 Colorectal Neoplasms 7 Head and Neck Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neuroendocrine Tumors 4 Leukemia, Myeloid, Acute 4 Urethral Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Glioblastoma 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Neuroendocrine 3 Carcinoma, Hepatocellular 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Penile Neoplasms 2 Pancreatic Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasm, Residual 2 Mesothelioma, Malignant 2

Interventions

Imatinib Mesylate 32 regorafenib 9 Sunitinib 9 Laparoscopy 5 Dasatinib 4 Blood Specimen Collection 4 pazopanib 3 nilotinib 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Paclitaxel 3 Observation 3 spartalizumab 2 ripretinib 2 envafolimab 2 binimetinib 2 apatinib 2 Temozolomide 2 Neoadjuvant Therapy 2 Ipilimumab 2 Gemcitabine 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 Capecitabine 2 CTLA-4 Antigen 2 Biopsy, Fine-Needle 2 Biopsy 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastrointestinal Stromal Tumors × avelumab × Clear all

NCT04258956 2025-09-11

AXAGIST

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡